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ABSTRACT 
 
EXPOSURES TO SILICA AND INDUCERS OF XENOBIOTIC 
METABOLISM IN THE RAT LUNG 
 
Lori A. Battelli 
 
CYP1A1 metabolizes polycyclic aromatic hydrocarbons (PAHs), such as those in 
cigarettes, to reactive intermediates which interact with DNA and lead to cancer.  Silica is 
a lung carcinogen.  Epidemiology studies of silica and lung cancer are not all positive.  A 
possible explanation for these inconsistencies may be that silica is a modifier of PAH 
metabolism and, thus, cigarette smoke carcinogenesis.  We hypothesize that crystalline 
silica exposure alters CYP1A1 expression, thereby modifying lung cancer risk.  
Rats exposed to both crystalline silica and the model PAH, β-naphthoflavone (NF), a 
CYP1A1 inducer have significantly decreased CYP1A1 enzymatic activity and CYP1A1 
protein expression.  In the proximal alveolar region of NF- exposed rats, silica exposure 
increases markers of alveolar type II cells but decreases proportional CYP1A1 expression 
in type II cells as detected by immunofluorescence.  Our experiments support the 
hypothesis that silica is a negative modifier of CYP1A1 induction by PAH.  
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Chapter 1 
Introduction 
Cytochrome P450s (CYPS) have been shown to play a key role in activating 
procarcinogens.  Cytochrome P4501A1 (CYP1A1) is responsible for the metabolism of 
polycyclic aromatic hydrocarbons (PAHs), such as those found in tobacco byproducts. In 
the early 1970s, cultured lymphocytes showed a link between high AHH (aryl 
hydrocarbon hydroxylase) activity and increased risk of lung cancer (Kellerman et al, 
1973).   CYP1A1 is an important enzyme involved in lung cancer initiation because it 
activates PAHs and is responsible for the expression of the AHH activity (Bartsch et al 
1992; Bartsch et al,1999; Kellerman et al, 1973). Experiments have shown that during 
CYP1A1 metabolism, PAHs are epoxidized, then hydrolyzed by epoxide hydrolase to a 
dihydrodiol and ultimately oxidized to the diolepoxide or ultimate carcinogen (Hasler et 
al, 1999).  These diolepoxides are highly reactive and can form DNA adducts leading to 
mutations and possibly activating oncogenes or tumor suppressor genes (Kondraganti, et 
al, 2002).   
Humans are continuously exposed to a variety of foreign compounds via lung 
inhalation.  These exposures can lead to alterations in the lung metabolism or cause 
cellular injury, or both.  Workers in both mining and non-mining (masonry, pottery, sand 
blasting) professions can be exposed to respirable silica.  Exposures to respirable silica 
can be both chronic and acute and can lead to silicosis, and related diseases such as 
silicotuberculosis, and scleroderma.  Although there have been inconsistencies noted in 
data associating risk of lung cancer and exposure to respirable silica, the International 
Agency for Research on Cancer (IARC) classified silica as a carcinogen in 1997.    Cocco 
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et al (2001) found an association between lung cancer and silica exposure that 
surprisingly was stronger in workers exposed to silica than workers exposed to both silica 
and PAHs.  PAHs, such as those found in cigarette smoke are known to increase the risk 
of developing cancer.   Knowing that both silica exposure and PAH exposure alone can 
increase lung cancer risk one might expect an additive effect when co-exposed.  
However, if silica modifies the carcinogenicity of the PAHs, these two lung carcinogens 
are not simple co-variables in causing lung cancers, but instead represent a complex risk. 
Experiments by Miles et al (1993; 1994) and Levy et al (1997) investigated the possible 
link between silicosis and lung cancer and more specifically, the possible role of the 
pulmonary microsomal cytochrome P450 system in the initiation of lung cancer.   In both 
studies, rats were intratracheally exposed to silica dust.  Miles et al showed that the 
pulmonary microsomal CYP system was altered by intratracheal silica exposure resulting 
in increased activity levels of both CYP2B1 and CYP1A1 (Miles et al, 1993; Miles et al, 
1994).  Immunohistochemical (IHC) staining in lung tissues was negative for CYP1A1 
expression in any cells.  CYP2B1 was found in Clara cells and alveolar type II cells, but 
was not significantly different between groups (Levy et al,1997).  
It is important to note that those experiments were done in lung that did not have 
CYP1A1 induced by PAH exposure.  Immunohistochemical experiments by Levy et al 
(1997) showed that the increase in CYP activity was not due to the proliferation of type II 
cells of silicosis. In addition, the major known effect of CYP1A1 is on the metabolism of 
PAHs.  Since PAHs both induce and are metabolized by CYP1A1, the effect of silica on 
CYP1A1 is most important where there are also exposures to PAHs. 
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Based on those previous experiments, our experiments involve the use of CYP 
inducers and IT silica exposure.  In the first experiment, we hypothesized that the new 
type II cells of silicosis were a potential site for CYP1A1 induction in the rat lung. Rats 
were exposed to silica and inducers of CYP – β-naphthoflavone, a CYP1A1 inducer; 
phenobarbital, a CYP2B1 inducer; or a combination of both.  Endpoints measured 
included IHC for both CYP1A1 and CYP-dependent xenobiotic activity (7-
ethoxyresorufin-O-deethylase (EROD) and 7-ethoxycoumarin-O-deethylase (ECOD) 
respectively).  
Based on results from the first experiment, we found it necessary to use 
immunofluorescence (IF), more specifically dual immunofluorescence to further 
determine the location of CYP1A1 in the lung.  IF was selected because it is more 
sensitive than enzymatic IHC and easily allows for double labeling the tissue for 2 
different proteins.  Images were digitally captured and changes quantified by 
morphometric analysis. The sites of CYP isoform localization were determined by 
measuring colocalization of a CYP1A1 fluorescent probe with a marker of a specific cell 
type.   In addition, the total area of the lung involved in CYP1A1 expression were 
measured  by use of these fluorescent probes and the percent of that area of expression 
localized to alveolar type II cells was calculated from the co-localization of CYP1A1 and 
cytokeratin 8, an alveolar type II cell marker.  Again, rats were exposed to silica and the 
CYP1A1 inducer β-naphthoflavone.  Endpoints included IF for CYP1A1 and cytokeratin 
8, Western blot for CYP1A1, CYP1A1-dependent activity (EROD) and CYP2B1 
dependent activity (7-pentoxyresorufin-O-deethylase (PROD)).    
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We also examined the hypothesis that the reduction of CYP1A1 activity by silica 
exposure was dose responsive, i.e., does this effect occur at low exposures and increase 
with increasing exposures.  All animals were induced with NF and IT exposed to 5, 10 or 
20 milligrams of silica.  Endpoints measured included CYP1A1 dependent activity 
(EROD), CYP2B1 dependent activity (PROD), and Western blots for both CYP1A1 and 
CYP2B1.   
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Objectives 
Study objectives: 
1. Determine the relationship between co-exposure to respirable 
silica dust and PAHs and  CYP1A1 expression. 
2. Determine the relationship between silicotic histopathologic 
lung changes and the pattern of CYP1A1 expression in 
alveolar epithelial cells. 
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Chapter 2 
 
Review of Literature 
 
 
1 - Cytochrome P450 (CYPs) 
 
Cytochrome P4501A1 is a part of the Cytochrome P450 superfamily.  CYPs are 
hemoproteins that are part of an enzyme system that help mediate xenobiotic metabolism.   
In the late 1950s, Klingenberg discovered this unique protein that was known as 
“microsomal carbon monoxide-binding pigment” (Omura, 1999; Estabrook, 1998).  
Omura and Sato discovered the hemoprotein nature of this pigment and proposed the 
name Cytochrome P450 due to its maximum optical absorption peak of 450 nm (Omura, 
1999; Estabrook, 1998).  In this same time period (early 1960s) Hashimoto, Yamano, and 
Mason discovered what they thought was a new compound in liver microsomes.  It 
turned out to be identical to Cytochrome P450 (Omura, 1999).  The exact nature and 
function of this hemoprotein was discovered in 1963.  Estabrook, Cooper, and Rosenthal 
were able to confirm that Cytochrome P450 was involved in hydroxylation reactions in 
1963 (Omura, 1999).  More experiments followed and Cytochrome P450 was found to be 
a mixed function oxidase, providing molecular oxygen to these reactions. 
The body is constantly exposed to foreign compounds and the majority of these 
compounds are metabolized through the cytochrome P450 system (Philpot and Smith, 
1984). There are two phases to these reactions, and CYPs participate in Phase I reactions. 
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Figure 1.  Phase I and Phase II Pathways.  Figure adapted from Timbrell, J.A., 1993  
Biotransfromation of Xenobiotics.  General and Applied Toxicology Vol 1,   (B. 
Ballantyne, T. Marrs, and P. Turner Eds.) Macmillan Publishing Co.  New York, pp 89 – 
116. 
 
Phase I reactions include hydrolysis, reductions, and oxidations of foreign 
compounds. During Phase I reactions, a functional group is added, making the compound 
slightly more water soluble and reactive.  Phase II reactions which include 
glucouronidations, sulfonations, acetylations and methylations conjugate the phase I 
metabolite, usually resulting in a large increase in water solubility and excretability by 
the compound.  The phase I metabolite is not stable, and can become reactive and lead to 
possible DNA damage.    Instead of detoxifying the xenobiotic compound, the opposite 
can occur with a resulting toxicity increase. 
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Figure 2.  Biotransfromation of Xenobiotics.  Adapted from Timbrell, J.A., 1993 General 
and Applied Toxicology Vol 1,   (B. Ballantyne, T. Marrs, and P. Turner Eds.) Macmillan 
Publishing Co.  New York, pp 89 – 116. 
 
Genome projects have helped established that CYPs arose from a single ancestral 
form.  Although the molecular species may be different, there are several conserved AA 
sequences found amongst all CYPs (Omura, 1999).  Some prokaryotes and all animals, 
plants, fungi and eukaryotic organisms have CYPs.  CYPs are found in the endoplasmic 
reticulum and can be species and tissue specific.  Their expression can be sex and 
developmentally regulated.  CYPs have been found to be involved in a variety of 
functions including the biosynthesis and metabolism of steroid hormones and the 
metabolism of various lipid biofactors such as eicosanoids, vitamin D3 and retinoids 
(Omura, 1999). 
Close to a thousand CYP isoforms have been found.  A nomenclature has been 
established placing the isoforms into families and subfamilies (Omiecinski et al, 1999). 
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CYP  - for Cytochrome P450 
# - for family (if the same number is used, this indicates greater than 40% protein 
sequence homology) 
Letter – for subfamily (CYPs are in the same subfamily if they have greater than 55% 
homology in the protein sequence) 
# - for gene 
For example, the CYP1 family is the family using the aryl hydrocarbon receptor pathway.  
There are 2 subfamilies, CYP1A and CYP1B.  The CYP1A1 subfamily is made up of 2 
genes, CYP1A1 which predominantly uses polycyclic aromatic hydrocarbons as 
substrates and CYP1A2 which predominantly uses aromatic amines as substrates.  
CYP1B1 predominantly uses heterocyclic amines as substrates (Omiecinski et al, 1999).  
Some CYPs are constitutively expressed and others are only expressed after induction.  
Expression varies by species and tissue also. 
 
2 - Cytochrome P4501A1 (CYP1A1) 
CYP1A1 is an inducible isoform and is involved in the metabolism of polycyclic 
aromatic hydrocarbons (PAHs).  PAHs are common in combustion products, including 
cigarette smoke.  CYP1A1 has been found in many tissues, including liver, lung, and 
brain.  Expression is usually only detectable after induction and varies between tissues.  
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Inducers of CYP1A1 are its substrates, the PAHs, which are present in cigarette smoke, 
charcoaled meat, soot and other common environmental contaminants.  Examples include 
3-methylcholanthrene (3-MC), β-naphthoflavone (NF), and dioxin (TCDD).  Induction 
can cause an imbalance in detoxification and activation (Whitlock, 1999; Whitlock et al 
1996). 
  PAHs induce their own metabolism; they are the substrate of CYP 
metabolism.  They are found almost everywhere in the environment and one can easily be 
exposed via inhalation, intestinal absorption through eating and drinking, or through skin 
absorbance.  PAHs are then metabolized by CYP1A1, with subsequent involvement of 
phase II metabolism. 
Induction of CYP1A1 by an inducer causes an increase in the transcription of the 
gene, leading to increased Phase I products, DNA adducts, and somatic mutations, which 
could then possibly lead to carcinogenesis (Mucci et al, 2001). 
There are several regulatory proteins involved in CYP1A1 induction.  The AhR 
(aromatic hydrocarbon receptor) and ARNT (aromatic hydrocarbon receptor nuclear 
translocator) both pre-exist in cells, making induction of CYP1A1 a primary response 
associated with protein synthesis.  Both AhR and ARNT are bHLH/PAS proteins (basic 
helix loop helix/pers-arnt-sim) that are involved in the regulation and maintenance of 
basic biological processes, homeostasis, circadian rhythms and development.  AhR is 
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located in the cytoplasm where the inducer can bind to it.  Two cytoplasmic factors, 
HSP90 (heat shock protein 90) and AIP (AhR-interacting protein) enhance receptivity for 
ligand and help maintain configuration for ligand binding.  After ligand binding, both 
factors dissociate and the liganded AhR is able to enter the nucleus and bind to ARNT.  
Together, this transcription complex binds to the enhancer element of the CYP1A1 gene.  
Components interact and the initiation complex forms at the promoter, thus starting 
transcription and leading to metabolism of the ligand (Whitlock, 1999; Hankinson, 1995). 
 
Figure 3.  Mechanism of CYP1A1 Induction.  Adapted  from James Whitlock et al, 1996. 
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3 - CYP1A1 and Carcinogenesis 
In general, CYP1A1 has low constitutive expression, but induction occurs rapidly 
and high expression can be induced.  CYP1A1 induction can lead to toxicity or 
carcinogenesis as a result of the oxidation of the PAHs.  For example, PAHs are found in 
cigarette smoke and their oxygenation by CYP1A1 generates arene oxides that can form 
DNA adducts resulting in lung cancer. 
    
CYP1A1 Catalyzed Reaction 
O
HO
OH  
Benzo(a)pyrene      Benzo(a)pyrene 
Procarcinogen       7,8 diol-9, 10 epoxide 
        Ultimate Carcinogen 
 
Figure 4.  CYP1A1 Reaction: Procarcinogen to Ultimate Carcinogen 
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Figure 5.   CYP1A1 Metabolism Pathways.  Adapted from Geacintov, N.E.; 
http://www.nyu.edu/projects/geacintov/images/WEB_Figures/WEB_PAH3.htm 
 
 
CYP enzymes have been studied for their role in the activation and detoxification 
of chemical carcinogenesis.   Causes of cancer vary and genetic factors, exposure to 
chemicals, and diet are all important considerations.   Genetics alone is only thought to 
account for about 5 % of all cancers (Perera, 1997).  The rest involved environmental 
factors which often interact with both genetics and susceptibility (Perera, 1997). 
 Guengerich and Shimada (1998) summarized evidence of a link between CYP enzymes 
and cancer: 
1 – cancer susceptibility associated with CYP activity. 
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2- variation in level of CYP enzyme basal expression on the individual exposure patterns 
(work, diet). 
3- variations in drug sensitivity and interactions. 
4 - Polymorphisms in CYPs   
Several CYP1A1 polymorphism have been found and there is a wide variety of 
levels of induced enzyme activity among individuals (Daly et al, 1998; Guengerich and 
Shimada, 1998).  In 1973, Kellerman first showed the association between high AHH 
inductions and bronchiogenic carcinomas in cultured lymphocytes (Smith et al, 2001).  
Recent studies have shown several prominent polymorphs associated with lung cancer.  
The  MspI mutation at the  3’ flank that causes a T to C transition and a mutation at the  
Exon 7 heme binding region  that causes an A to G transition which leads to an ILE to 
VAL substitution are two well known polymorphism in the CYP1A1 gene.  A third 
polymorphism has also been found exclusively among people of African origin – 
MSP1AA (Smith et al, 2001).  Most studies on human polymorphisms of CYP1A1 and 
AhR are still controversial.  Some studies have shown increased risk for lung cancer in 
specific ethnic groups and differences between male and female sex populations for 
individuals carrying one copy of the variant allele (Smith et al, 2001). There is a wide 
variance in CYP1A1 expression (50X) in human lung tissue, perhaps explaining the 
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varying outcomes between studies.  The variation can be due to both genetic 
polymorphism  or other genes involved in CYP1A1 expression (Alexandrov et al, 2002). 
Cigarette smoking has long been considered an important factor in lung cancer.  
Cigarette smoke contains PAHs that are bioactivated by CYP1A1.  The link between 
CYP1A1 polymorphism and lung cancer is still controversial and results are conflicting 
(Smith et al, 2001). 
We must also consider the phase II enzymes and their role in carcinogenesis.  
They are responsible for detoxifying the reactive metabolite that is the product of phase I 
metabolism.  Examples of phase II enzymes include transaminases, acetyltransferases,  
UDP glucuronyl-, and glutathione-S-transferases (GSTs) that play a huge role in the 
detoxification of endogenous and exogenous compounds.  There are several 
polymorphisms of GSTs and in most cases, the polymorphs are less effective in the 
detoxification processes, leading to an increase in cancer risk (Mucci et al, 2001). 
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5 - Lung physiology 
 
Figure 6.  Diagram of lung alveolus.  Adapted from 
http:www.biology.arizona.edu/chh/problem_sets/lung_toxicology/graphics/alveolus. 
 
 
Over 40 different cell types have been identified in the lung.  There are several 
that are important in our research.  Alveolar type I cells facilitate gas exchange, help 
maintain the alveolar structure, and comprise 96% of the alveolar surface.  Alveolar type 
II cells account for 10 – 15 % of all lung cells but only 4% of the surface area of the 
alveoli (Castranova et al, 1988).  On a cell number basis, the type II cells account for 
60% of all alveolar cells.  Type II cells synthesize and secrete surfactant and are the 
progenitors of the type I cells.   Type II cells also have roles in xenobiotic metabolism 
and lung damage repair.  Once stimulated, they release cytokines and recruit neutrophils.  
Another epithelial cell, the Clara cell is a non-ciliated airway epithelial cell found mostly 
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in bronchioles.  These cells can differentiate into ciliated cells, participate in xenobiotic 
metabolism and possibly have a role in surfactant production (Devereux, 1984).   
 
Figure 7.  Example of terminal bronchi and Clara Cells.  Adapted from 
http://www.bu.edu/histology/p/13805loa.htm. 
 
Another distinct lung cell type, the alveolar macrophage acts as the first line of 
defense against inhaled particles and bacteria by engulfing the foreign particles.  Several 
studies have been performed showing xenobiotic metabolism in the alveolar Type II cell 
and the Clara cell (Devereux, 1984).  Methods for isolating several cell types have been 
discovered enabling us to conduct toxicological and mechanistic studies on specific cells 
(Castranova et al, 1988). 
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Many xenobiotic compounds are aerosolized and easily inhaled by the lungs, 
making the lungs an easy target organ.   In addition, the lung is a highly vascular organ 
which makes it a potential target organ for circulating xenobiotics.  Lung injury can vary 
depending on physical and chemical nature of compound, size and concentration of 
particle and the potential clearance of the agent (Thiedemann, et al, 1991).   The lung has 
two major clearance mechanisms – ciliated epithelium in the trachea and bronchi and 
phagocytosis by alveolar macrophages (Stuart, 1976).  Particles can become trapped in 
the lung and the resulting persistence facilitates alterations in lung tissues.  Chronic and 
high exposures to respirable particles can cause overload and lead to fibrosis and cancers 
(Thiedemann et al, 1991; Oberdörster et al, 1997).  Lung particle overload is associated 
with lung inflammation, accumulation of particles in centriacinar interstitial and alveolar 
areas of the lung, type II cell proliferation, and impaired macrophage clearance ability in 
the rat lung (Oberdörster et al, 1995; ILSI Risk Science Institute Workshop, 2000). 
6 – Respirable Crystalline Silica 
Respirable sized particles reach the alveolar region of the lung.  In experimental 
animal research, there are 2 common ways to expose animals to particles – inhalation or 
intratracheal instillation.  Both procedures have advantages and disadvantages.  
Intratracheal instillation is inexpensive and a known amount of material is dosed to the 
lung.  However, this method does not accurately reflect human exposures to particles. 
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Research has shown differences in particle distribution, clearance and injury pattern. The 
particle distribution is less homogenous in intratracheal instillations than in inhalation 
exposures, creating a variance of particle burden in the lung (Osier and Oberdörster, 
1997).  It has been reported that at low level particle exposures the total lung burden is 
not different between the techniques (Ferin and Feldstein, 1978).  A comparison study 
determined that either method was useful to assess pulmonary responses (Henderson et 
al, 1995).  Inhalation can be very expensive and the amount of dosed material is not 
measured as accurately, but this is the more natural exposure method.  (Brain et al, 1976; 
Osier and Oberdörster, 1997; Driscoll et al, 2000). 
Crystalline silica has many polymorphic forms – α-quartz, β-quartz, crystoballite 
(NIOSH Hazard Review, 2002).  Individuals can be exposed to crystalline silica in 
several occupational settings (e.g. coal mining, sand blasting) if protective measures are 
not taken.  Silicosis is chronic lung disease caused by inhalation exposure to respirable 
crystalline silica.   Silicosis can be acute (short exposure to a high concentration) or 
chronic (long exposure to low concentration).  It can also be latent, occurring years after 
the initial exposure to silica.  In 1997, IARC found enough evidence to add respirable 
crystalline silica to its list of agents that are carcinogenic to humans (IARC Monograph, 
1997). 
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Respirable exposure to crystalline silica causes an inflammatory response in 
pulmonary cells and tissues (Castranova, 2000; Porter et al, 2001; Driscoll et al, 1990; 
Driscoll et al, 1991).  Several cell types are involved in the development of silicosis.    
Macrophages try to engulf the particles and phagocytose them (Miller et al 1986; Miller 
et al 1987; Miller and Hook, 1990).  Lavage studies have shown increases (2x control) in 
the number of polymorphonuclear leukocytes (PMN’s) in silica exposed rats, indicating 
inflammation.  Surfactant production is increased in the alveolar type II cell and they  
become hyperplastic and hypertrophied in response to silica (Miller et al, 1987).  Total 
protein and phospholipid numbers in bronchial lavage fluid also increase in the silica 
exposed lung (Dethloff et al, 1986; Miles et al, 1993; Miles et al, 1994).  The type I cell 
is damaged and stimulates proliferation of the type II cell to replace the dead type I cell 
(hyperplasia).  Surfactant production increases; the type II cells of silicosis frequently 
contain abundant surfactant apoprotein and are enlarged (hypertrophic) (Miller and Hook, 
1990). 
Reactive oxygen species (ROS) are also generated during chronic silica exposures 
(Vallyathan et al, 1998).  ROS are produced at both the particle surface and by the 
phagocytizing cells engulfing the particle (Fubini and Hubbard, 2003).  ROS cause 
cytotoxic lung injury through release of oxidants.  These oxidants activate cell signaling 
pathways, enhancing inflammatory cytokine expression, and activating transcription 
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factors.  Oxidant effects include NFКB activation, AP-1 activation, and TNF alpha 
production.  Apoptosis can also be induced by ROS (Fubini et al, 2003). 
Oxidants can activate oncogenes or inactivate tumor suppressor genes and lead to 
carcinogenesis.  Hydroxy radicals (·OH) have been shown to cause DNA breaks and 
damage that can lead to carcinogenesis via point mutations and deletions (Jackson, 1994).  
The release of inflammatory cytokines such as TNFα and IL1β, and IL6  has been 
shown to inhibit CYP1A1 expression (Jackson, 1994; Morgan, 2001).   The mechanism 
of this down regulation is still being investigated.   Several findings include: 
The release of TNF alpha can induce the release of NO, which is then able to bind 
to the heme portion of the CYP.  This binding then inhibits activity of the enzyme.  NO 
can also react with oxygen causing a loss in catalytic activity (Paton and Renton, 1998). 
NFКB is also induced by TNFα.  NFКB plays an important role in several necessary 
biological processes, including - immune response, inflammatory regulation, cell 
proliferation, apoptosis, and developmental processes (Ke et al, 2001). 
NFКB is a heterodimer made up of p65 (relA) and p50.  A link between the AhR and 
NFКB signaling pathway indicates a mechanism for inflammatory mediators to inhibit 
CYP1A1 expression (Ke et al, 2001).  RelA (P65 subunit of NFКB) and AhR complexes 
interact and RelA is able to inhibit activation of CYP1A1 transcription (Tian et al, 1999).  
Ke et al, (2001) suggests that the activation of NFКB remodels the chromatin of the 
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CYP1A1  promoter.  Their data suggest a possible mechanism for the suppression of 
CYP1A1 by inflammation – pro-inflammatory cytokines such as TNFα induce NFКB,  
the RelA subunit interacts with AhR and inhibits activation resulting in down regulation 
of CYP1A1 expression (Ke et al 2001; Tian et al, 1999; Tian et al, 2002). 
 
 
 
 
 
 23
                                                                                                     
Chapter 3 
 Methods and Materials 
 
1 - Preparation of Silica  
Crystalline Silica (α-quartz) was obtained from Min-U-Sil, (U.S. Silica, Berkeley 
Springs, WV). It was fractionated to < 5 um using a Donaldson particle classifier. By X-
ray diffraction (XRD) it was pure crystalline silica (99.8%) and by X-ray spectrometry 
(particle analysis) it was 98.7% pure.  Surface area measurements were done by nitrogen 
adsorption technique.  Mean surface area of < 5 Min-U-Sil is 4.7 m2/gram. Mass median 
aerodynamic diameter (MMAD) of silica is 3.5 um.  Prior to instilling, the silica was 
sterilized by heating overnight in an oven at 160°C.   Sterile silica particles were weighed 
and then suspended in 0.9 % sodium chloride (Abbot Laboratories, North Chicago, IL) to 
produce 5, 10, or 20 mg/0.5 ml solutions.  Representative samples of the sterilized silica 
and the saline solution were analyzed for endotoxin.  Measurements were determined by 
the Limulus Amebocyte Lysate assay (BioWhitaker, Walkersville, MD).  
2 - Preparation of CYP Inducers    
Corn oil (Mazola, Englewood Cliffs, NJ) was filtered through a 0.2 µm  
membrane syringe filter.  A 100mg/ml solution of Phenobarbital (Sigma Chemical, St. 
Louis, MO) was prepared with corn oil.  50 mg/ml solution of β-naphthoflavone (Sigma 
Chemical, St. Louis, MO) was prepared with corn oil. These solutions were mixed in 
sterile centrifuge tubes, vortexed and then sonicated for at least 20 minutes. 
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3- The Rat Model of Silicosis     
Male, Sprague-Dawley, Hla:(SD)CVF rats (Hilltop Lab Animals, Scottdale, PA) 
weighing between 125 and 150 grams on arrival were used for these experiments.  Rats 
were housed in shoebox cages supplied with HEPA-filtered laminar flow air with Alphi-
Dri Virgin cellulose chips (Sheperd Specialty Papers, Watertown, TN) and hardwood 
Beta-chips (NEPCO, Warrensburg, NY) for bedding, and provided tap water and 
autoclaved ProLab 3500  (Purina Mills Incorporated,  St. Louis, MO) rodent diet ad 
libitum.  Rats were allowed to acclimate to the animal facility for one week.   
Prior to exposure, rats were randomly placed into exposure groups using  a table 
of random numbers.  Animals were anesthesized with an intraperitoneal injection (IP) of  
35/mg/kg Brevital Sodium (Methohexital sodium, Eli Lilly and Co., Indianapolis, IN) 
and received an intratracheal instillation (IT) of  0.5 ml of the silica suspension (5, 10 or 
20 mg crystalline silica) or the vehicle alone (0.9% sodium chloride).  To determine if 
silicosis suppressed the induction of CYP1A1 or the constituitive expression of CYP2B1 
in the lung, rats with and without silicosis were exposed to the CYP1A1 inducer, β-
naphthoflavone (NF). Some of these rats were exposed to the hepatic-specific CYP2B1 
inducer,  phenobarbital, because phenobarbital is a CYP2B1 inducer in the liver and has 
not been investigated in the silicotic lung. 
4 -  Experiment 1; Exposures to Silica (IT) Classical Inducers of CYP1A1 and 
CYP2B1  
Seventeen rats received intratracheal instillations of 20 mg  silica and twenty rats 
received saline. Rats were sacrificed 14 days post IT exposure. Rats received CYP 
inducer and/or vehicle via intraperitoneal injection on days 11 and 13 after IT instillation 
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as outlined in table M1.  These treatments resulted in the following groups of rats: control 
rats, rats with NF induced pulmonary CYP1A1, phenobarbital exposed rats, 
phenobarbital exposed rats with NF induced CYP1A1, silica exposed rats, silica exposed 
rats with NF induced CYP1A1, silica and phenobarbital exposed rats, and silica  and 
phenobarbital exposed rats with NF induced CYP1A1. 
Table M1: Experimental Design 
Group Control  CYP1A1 
induced 
Phenobarbi
-tal 
exposed 
Phenobarbi-
tal exposed 
& CYP1A1 
induced 
Silica 
Exposed 
Silica 
Exposed 
& 
CYP1A1 
induced 
Silica & 
Pheno-
barbital 
exposed 
Silica & 
Pheno-
barbital 
exposed 
& 
CYP1A1 
induced 
Intratra-
cheal 
instilla-
tion 
Day 0 
Saline 
0.5 ml 
Saline 
0.5 ml 
Saline 
0.5 ml 
Saline 
0.5 ml 
Silica 
20 mg 
Silica 
20 mg 
Silica 
20 mg 
Silica 
20 mg 
Intraperito
neal 
injection 
Day 11 
Corn 
Oil 
NFa PBb NFa & PBb Corn oil NFa PBb NFa & 
PBb 
Intraperito
neal 
injection 
Day 13 
Corn 
Oil 
Corn Oil PBb PBb & 
Corn oil 
Corn 
Oil 
Corn Oil PBb PBb & 
Corn 
Oil 
# of 
animalsc 
5 5 4 5 4 3 4 4 
a. NF = β-naphthoflavone (50 mg/kg) in corn oil; 
b.  PB = Phenobarbital(100mg/kg) 
c.  Number of animals remaining at time of sacrifice.  Experiment started with 5 
animals per group.  Animal deaths resulted from intraperitoneal injections. 
 
End Points Measured: Pulmonary CYP1A1 and total CYP activity were measured 
with EROD and ECOD activity, respectively.  CYP1A1 and CYP2B1 lung tissue 
expression was  localized  with enzymatic immunohistochemistry to the sites of 
expression.  Histopathology was performed to assess lung injury. 
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5 - Experiment 2: Exposures to Silica and BNF, a Classical Inducer of CYP1A1     
12 rats were intratracheally instilled with 20 mg silica and another 12 rats instilled 
with saline.  11 days after instillation, 6 rats from each group were weighed and injected 
intraperitoneally with 50mg/kg β-naphthoflavone or vehicle alone (corn oil). 
Table M2: Experimental Design for Experiment 2 
Group Control NF exposed Silica exposed Silica & NF 
exposed 
Intratracheal  
Instillation 
Saline Saline Silica Silica 
 
CYP1A1 
Inducer 
 
Corn Oil NF Corn Oil NF 
# of animals 6 6 6 6 
NF = β-naphthaflavone in corn oil 
End Points Measured: CYP1A1 and CYP2B1 activity were measured by EROD 
and PROD activity respectively.  CYP1A1 protein was measured by western blot, and 
CYP1A1 expression was localized within lung tissue by CYP1A1 immunofluorescence 
using dual immunofluorescence wih cytokeratin 8, a marker of alveolar type II cells in 
the lung alveolus.  Histopathology was used to assess lung injury. 
 
6 - Experiment 3: Silica Dose Response Study with Exposure to Classical Inducer of 
CYP1A1   
Five rats were intratracheally instilled with saline, 5 mg silica, or 10 mg silica and 
four rats  were intratracheally instilled with  20 mg silica.  Eleven days later, all rats 
received a 50 mg/kg IP injections of NF. 
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Table M3: Experimental Design for Experiment 3 
Groups NF Control NF/low dose NF/mid dose NF/high dose 
Intratracheal  
Instillation 
Saline 5 mg Silca 10 mg Silica 20 mg Silica 
 
CYP1A1 
Inducer 
 
NF NF NF NF 
# of animals* 5 5 5 4 
NF = β-naphthaflavone in corn oil 
* = Number of animals at time of sacrifice.  One animal died as a result of 
intraperitoneal injection. 
 
End Points Measured: CYP1A1 and CYP2B1 activity were measured by EROD 
and PROD activity, respectively.  CYP1A1  and CYP2B1  protein were measured by 
western blot.  Histopathology was used to assess lung injury. 
7 - Tissue Collection (Experiments 1, 2, and 3)    
 On day 14 after intratracheal instillation, the rats were euthanized.  The rats were 
euthanized by an intraperitoneal injection of an overdose of sodium pentobarbital 
followed by exsanguination  via transection of the abdominal aorta.  The lungs were 
removed and the right lung lobes were isolated, tied off and removed.  The right lung 
lobes were placed on ice and microsomes were isolated as subsequentially described for 
biochemical analysis.  The left lung lobe was inflated via the trachea with 3 ml of neutral 
buffered formalin, tied off and placed in a sealed bag with 10% neutral buffered formalin 
(10% NBF).  The tracheobronchial lymph node, parathymic lymph node, liver and kidney 
were also collected and placed in 10% neutral buffered formalin. 
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8 - Biochemical Analysis; Preparation of Lung Microsomes (Experiments 1, 2, and 
3)  
  Microsomes were prepared as described by Miles et al, 1993 and Ma et al, 2002.  
At necropsy, the right lung lobes were weighed and placed on ice.  The lung tissue was 
was chopped using a McIllwain tissue chopper (The Mickle Engineering Co., Gomshall, 
Surrey, UK).  Tissues were chopped atleast 4 times with slice thickness set at 5 mm.  Ice 
cold buffered solution (145mM KCl, 30mM Tris-HCl, 1.9mM KH2PO4,  and 3mM 
MgCl2, pH 7.4) was added to the tissue homogenate at 25% wt/vol ratio.  A teflon-glass 
Potter-Elvejhem homogenizer was used to make a homogenate (16 complete passes with 
the pestle).  Four sequential centrifugaions were performed to obtain the microsomal 
fraction.  The first spin was for 10 minutes at 1000 times g.  The next three 
centrifugations were for  20 minutes each at 3,000, 10,000, and 15,000 times g.  Using an 
ultracentrifuge, the microsomal fraction was obatined by centrifuging at 105,000 x g for 
75 minutes.  The microsomal pellet was resuspended in cold buffered solution, aliquoted  
and frozen at -80°C. 
9 - Biochemical Analysis; Measurement of CYP1A1 protein activity by 
Ethoxyresorufin-O-deethylase (EROD) Activity (Experiment 1, 2, and 3)   
  CYP1A1 protein activity was measured in isolated microsomes stored at -80C.  
EROD  was measured as previously described (Burke and Mayer, 1974; Burke et al, 
1985; Miles et al, 1993).  Reactions were carried out in  fluorimeter cuvettes that 
contained 150 µl of microsomes, 2.78 ml phosphate buffer (145 mM KCL, 1.9 mM 
KH2PO4, 8.1 mM K2HPO4, 30 mM Tris-HCL, and 3 mM Mg Cl2; pH 7.6), 9 µl 7-ethoxy-
resorufin (3 µM), 7.5 µl dicumarol (25µM).  The dicumarol was added to prevent the 
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interference resulting from the elevated quinone oxidoreductase levels found in 
preparations from animals pretreated with xenobiotics (Burke et al, 1985). The mixture 
was allowed to equilibrate for 1 minute at 37oC  and then 50 µl of reduced form of 
NADPH (28.8 mM) was added to initiate the reaction.  The reaction for the first 
experiment was carried out for 8 minutes and was measured at various time points to 
replicate the method of Miles and co-workers (Miles et al, 1993).  For the second and 
third experiments, the reaction was measured by measuring the optical density every 
minute for 10 sequential minutes (Ma et al, 2002).  Under these conditions, increases in 
the fluorescence are due solely to CYP dependent formation of a single metabolite, 
resorufin, from the substrate used (Burke et al, 1985).  The flourimetric settings were 530 
nm and 585 nm for the excitation and emission respectively, and 6.5 nm for the excitation 
and emission slit.  A standard curve was determined after each run using a 10 µM 
resorufin solution prepared from 2.35 µg resorufin in 1 ml DMSO.  For compatability 
with the previous experiments of Miles and co-workers (Miles et al 1993; Miles et 
al,1994) EROD activity for the first experiment was expressed as pmol/mg/microsomal 
protein/8 minutes or as pmol/lung/8 minutes.  For the second and third experiments, 
EROD was expressed as pmol/min/mg microsomal protein or pmol/min/lung for 
comparability with other studies of particle effects in the lung (Ghanem et al, 2004).  
 
10 - Measurement of Cytochrome P450 – ECOD   (Experiment 1)   
ECOD was measured as previously described (Ullrich and Weber, 1972; Burke et 
al, 1985; Miles et al, 1993).  As with EROD, the activity of ECOD was measured using 
microsomes stored at -80۫ C.  The cuvettes contained a total volume of 6 ml, which 
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contained of  0.1mg protein per milliliter incubation medium lung microsomes, 0.5mg/ml 
bovine serum albumin, 0.48 mM NADPH, and 0.5 mM  of 7-Ethoxycoumarin -O-
deethylase.  The reaction was initiated by the addition of 7- Ethoxycoumarin -O-
deethylase in dimethyl sulfoxide (DMSO) (5µl/ml) and carried out at 37 ۫C for 30 
minutes.  Umbelliferone, the reaction product, was measured after 30 minutes using a 
fluorometer as described by Ullrich and Weber, 1972.  A model LS-50 Luminescence 
Spectrophotometer (Perkin-Elmer Corp., Norwalk, CT) was used for measurements and 
results were expressed as pmol/mg/microsomal protein/30 minutes or pmol/lung/30 
minutes.  
 
11 - Measurement of the CYP2B1 - Dependent Enzymatic Activities 
(PROD) (Experiments 2 and 3)  
This assay was performed as previously described (Burke et al, 1985; Ma, et al, 
2002).  The procedure was similar to EROD except the sample volume of the 
microsomes used was increased (300 µl).  Also the substrate used for the reaction was 7-
pentoxy-resorufin.  Resorufin was also used to determine the standard curve.  Results 
were expressed as pmol/min/mg/microsomal protein or pmol/min/lung. 
  
12 - Determination of the Total Lung Proteins: (Experiments 1, 2, and 3)       
The bicinchonicic acid (BCA) method (Pierce, Rockford, IL) was used to measure 
the protein content of the lung microsomes.  Bovine serum albumin was used as the 
standard and the 96 well plates were read on a spectrophotometer (Spectramax 250, 
Molecular Devices Corporation, Sunnyvale, CA).  
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13 - Western Blot Analysis – (Experiment 2 and 3:CYP1A1, Experiment 3: 
CYP2B1)     
Lung microsomes were used to quantify the amount of CYP1A1 or CYP2B1 per 
mg microsomal protein.  The procedure was performed as described by Ma et al, 2003.  
Microsome samples were thawed on ice and protein was placed in an eppendorf tube (75 
µg for Experiment 2 CYP1A1, 37.5 µg for Experiment 3 CYP1A1, and 20 µg for 
Experiment 3 CYP2B1).   BNF treated rat liver microsomes (Xenotech, Kansas City, 
Kansas)  diluted 1:100 with 2X loading buffer (Invitrogen, Carlsbad, CA) were used at a 
positive control for CYP1A1 expression  and phenobarbital treated rat liver microsomes 
(Xenotech, Kansas City, Kansas) diluted 1:10 with 2X loading buffer were used as a 
positive control for CYP2B1.  The rainbow color marker (Multimark™, Invitrogen, 
Carlsbad, CA), and the molecular weight marker (Magicmark™, Invitrogen, Carlsbad, 
CA) were mixed 1:2 with 2X SDS Loading buffer (Invitrogen, Carlsbad, CA).  All 
samples were then vortexed, heated at 95 ۫C for 5 minutes and allowed to cool before 
vortexing again and centrifuged for 10 – 15 seconds.   1.5 mm tris-glycine gels 
(Invitrogen, Carlsbad, CA) were used to load the samples.  Microsome samples were 
loaded into the gel.  10 µl of positive control and color marker, and 5 µl of molecular 
weight marker were also loaded on every gel.  Gels were electrophoresed in 1X running 
buffer (Invitrogen, Carlsbad, CA) using an Xcell SureLock Mini Cell™ (Invitrogen, 
Carlsbad, CA) with a BIORAD power supply (BioRad, Hercules, CA).   After 90 minutes 
at 125 volts, the gels were removed and transferred onto nitrocellulose membranes using 
the Xcell II™ Blot Module (Invitrogen, Carlsbad, CA).  The transfer was completed after 
90 minutes at 25 volts in transfer buffer.  Gels were then discarded and the membranes 
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were blocked with a 5% milk solution  for at least one hour on a rocker.  The membranes 
were then washed in tris-buffered saline with 0.1% Tween (TBS-T) for 5 to 15 minutes.  
The primary antibody, a polyclonal, affinity purified rabbit anti-rat CYP1A1 (Xenotech, 
Kansas City, Kansas) or Mouse anti-rat CYP2B1 (Xenotech, Kansas City, Kansas) was 
diluted 1:1000 with 1% milk and allowed to incubate on the membrane overnight on a 
rocker at 4 C.  The membrane was then washed in TBS-T for 5 to 15 minutes each before 
applying the secondary antibody.    The secondary antibody  was either HRP conjugated  
goat anti-rabbit IgG (for CYP1A1) or goat anti-mouse IgG (for CYP2B1) (SantaCruz 
Biotechnology, Santa Cruz, CA) and was diluted 1:2000 in 1% milk.  Incubation was at 
room temperature for one hour on a rocker.  Membranes were washed again and 
detection was performed using chemiluminescent reagent (ECL2109, Amersham 
Buckinghamshire, England).  The membranes were incubated for 1 minute with the ECL 
reagents, blotted, covered with plastic and exposed to undeveloped film for 30 to 60 
seconds.  Film was developed using an automatic developer (Kodak, Rochester, NY). 
Film images were scanned using the Eagle Eye II (Stratagene, La Jolla, CA)                  
and the scanned images were quantified using commercial morphometry software (Image 
Quant 5.1 Molecular Dynamics/Amersham Biosciences, Piscataway, NJ).  The volume of 
each band was quantified 3 separate times and averaged.  Data were compared as percent 
positive control.  Negative numbers were considered as zeros. 
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14 - Histologic Processing of Tissues (Experiments 1, 2, and 3)    
A section of the left lung lobe was processed and embedded in paraffin within 24 
hours of necropsy.    The remaining tissues were stored in 10% NBF until processing.  
Slides stained with  Hematoxylin and Eosin (H & E) and Masson’s Trichrome were 
prepared from the left lung.  Additional tissue sections of each left lung lobe block were 
cut at 5 microns and placed on silane treated slides (ProbeOn Plus, Fisher Scientific, 
Pittsburgh, PA) for immunostaining.  
15 - Hematoxylin and Eosin Staining of tissues (Experiments 1, 2, and 3)   
The slides were stained on the Shandon Lipshaw Linistain GLX (Thermo 
Shandon, Pittsburgh, PA) slide stainer.  The stainer is set up as follows: 5 baths of xylene, 
100% alcohol, 95% alcohol, distilled water, Harris hematoxylin, distilled water, bluing 
solution, distilled water, 95% alcohol, eosin 95% alcohol and 100% alcohol.   The slides 
were placed on the slide stainer and heated at 65° C for several minutes before being 
placed in the first bath.  Each bath is approximately 30 seconds long.  At the end, the 
slides were incubated in xylene and coverslipped with Permount.   
16 - Masson’s Trichrome Staining of tissues (Experiments 1, 2, and 3)  
The slides were deparaffinized as follows:  3 baths of xylene for 6 minutes each, 
and a 3 minute bath in each of the following:  100% alcohol, 95% alcohol, and 80% 
alcohol. The slides were finally placed in distilled water for at least 5 minutes before 
beginning staining. Staining was performed as described by Masson, (1929). Using glass 
staining dishes, slides were placed in Bouin’s solution for 1 hour at 56 ۫C then rinsed in 
running water until yellow color disappears.  Slides were rinsed in distilled water and 
placed in Weigert’s iron hematoxylin for 10 minutes and then rinsed in running water for 
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10 minutes.  After another rinse in distilled water, slides were placed in Biebrich scarlet-
acid fuchsin solution for 2 minutes and rinsed in distilled water.  Slides were then placed 
in Phosphomolybdic-phosphotungstic acid solution for 10 to 15 minutes, followed by a 5 
minute bath in Aniline blue solution.  The slides were rinsed in distilled water, placed in 
glacial acetic acid solution for 3 to 5 minutes, and dehydrated and mounted with 
permount.    
17 - Histopathology: Experiments 1, 2, and 3 
Tissue sections from all experiments were examined by a board certified 
veterinary pathologist who was blinded to exposure status.  Tissue sections from the third 
experiment were scored semi-quantitatively for statistical analysis as previously 
described (Hubbs et al, 1997).  The severity and distribution of the morphologic changes 
were recorded and converted to quantitative scores for each slide.  The numerical 
transformation is given in Table M4. The pathology score is the sum of the severity and 
distribution scores which produces a score with a potential range from 0 – 10. 
Table M4 
Score Severity Distribution 
0 None None 
1 Minimal Focal 
2 Mild Locally extensive 
3 Moderate Multifocal 
4 Marked Multifocal and Coalescent 
5 Severe Diffuse 
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18 - Enzymatic Immunohistochemistry for CYP1A1 (Experiment 1) 
A modification of the labelled streptavidin-biotin (LSAB) procedure provided by 
the manufacturer in the commercial kit (LSAB2 Kit, DAKO, Carpinteria, CA) was used 
in these studies.  In this procedure, slides are deparaffinized, antigenicity is retrieved, 
non-specific peroxidase activity and binding is blocked, a primary antibody is applied , 
followed by a biotinylated secondary antibody and a streptavidin–enzyme complement.  
A substrate chromogen is applied to visualize the color reaction and location of the 
antibody. 
 For each animal, a slide was incubated with rabbit anti-CYP1A1 polyclonal 
antibody or rabbit control serum (negative  control).  Because β-naphthaflavone (NF) is a 
strong inducer of CYP1A1, a slide from an animal treated with IT saline and IP NF was 
included with every group of slides stained to serve as a positive control. 
  Deparaffinizing: The slides were heated in an oven at 65° C for 20 minutes 
and deparaffinized in fresh solutions of xylene and alcohols.  Deparaffinization consisted 
of  six 30 second baths of xylene,  one 30 second bath of 100% alcohol and a 30 second 
bath of 95% alcohol, and a 5 minute bath in distilled water.   
Blocking for non-specific peroxidase activity and binding: After deparaffinizing,  
slides are placed in a humidity chamber and 3% hydrogen peroxide solution  was dropped 
on the slides  for a 5 minute incubation at room temperature.  Slides were rinsed with 
distilled water and Tissue Conditioner (Biomeda, Foster City, CA) was applied for 5 
minutes at 37° C.  Slides were blotted and placed in a coplin jar with  Tris Buffered 
Saline (TBS (Dako, Carpinteria, CA) for 5 minutes at room temperature.   
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Primary antibody application: The primary antibody, rabbit anti-rat CYP1A1/1A2 
(Amersham, Buckinghamshire, England) was reconstituted by adding 300 microliters of 
1% BSA/PBS and then diluted 1:4 with Antibody Diluent (Dako, Carpinteria, CA).  
Rabbit control serum (Biogenex,  San Ramon, CA) was applied  in place of the primary 
antibody on negative control slides. The primary antibody or control rabbit serum were 
applied and the slides incubated overnight at room temperature in the humidity chamber.   
Secondary antibody, label antibody and chromogen application: The following 
morning the slides were rinsed with distilled water and placed in TBS for 5 minutes.   
The secondary antibody, biotinylated anti-rabbit immunoglobulins (LSAB2 KIT, Dako, 
Carpinteria, CA) was dropped on the slides, and the slides were incubated  for thirty 
minutes at room temperature in the humidity chamber.  The slides were rinsed with 
distilled water and placed in TBS for 5 minutes at room temperature.  For labeling, 
streptavidin peroxidase (LSAB2 Kit, Dako, Carpinteria, CA) was dropped on the slides 
for thirty minutes at room temperature.  After rinsing in distilled water and incubating for 
5 minutes in TBS,  the chromogen, 3-Amino-9-ethylcarbazole (AEC) (Dako, Carpinteria, 
CA) was applied for 15 minutes at room temperature.  These procedures were done 
according to the directions from the manufacturer, Dako (Carpinteria, CA). 
Counterstaining and coverslipping: The slides were rinsed in distilled water and 
counterstained with Aqueous Hematoxylin (Biomeda, Foster City, CA) for 1 – 2 minutes.  
The slides were rinsed with tap water and covered with Crystal Mount (Biomeda, Foster 
City, CA) mounting media.  The slides were allowed to completely dry before 
coverslipping with a coverglass and Permount (Fisher Scientific, Pittsburgh, PA).   
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Slide Visualization and Morphology: Using an image analysis system (Image-1, 
Universal Imaging, West Chester, PA) the slides were morphologically quantified.   From 
8 to 10 small airways per slide, the number of positive CYP1A1 staining Clara cells per 
mm basement membrane were counted and recorded.  Ten different frames of alveolar 
regions measuring 0.035 mm2  each were examined and the number of CYP1A1 positive 
plump epithelial cells were counted and recorded. 
 
19 - Enzymatic Immunohistochemistry for CYP2B1 (Experiment 1) 
The same procedure as previously described for CYP1A1 was  used for CYP2B1 
immunohistochemistry except for the use of a different primary antibody with a different 
dilution and  incubation time.  The primary antibody (rabbit anti-rat CYP2B1, 
Amersham, Buckinghamshire, England) was reconstituted with 300 µl of 1% BSA/PBS.  
The primary antibody was then diluted 1:10 with diluent (Dako, Carpentira, CA) and 
dropped on the slides.  The slides were incubated overnight at 4°C in the humidity 
chamber.  Non-immune rabbit serum was applied to selected slides as a negative control.  
Image analysis was also performed as described above. 
20 - Immunofluorescence Staining for CYP1A1/Cytokeratin 8 (Experiment 2)   
Dual immunofluorescence for CYP1A1 and cytokeratin 8 was performed on the 
lung tissue to further define the location of CYP1A1 in the alveolus during silicosis and 
xenobiotic (BNF) exposure.  Cytokeratin 8, is an intermediate filament which is part of 
the cytoskeleton in alveolar epithelium of the rat (Schlage  et al, 1998).  Cytokeratin 8 
expression is generally weak in alveolar type I cells when compared to alveolar type II 
cell expression and was used to identify type II cells within the pulmonary alveolus.   
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Preparation of slides for reacting with primary anitbodies:  Slides were heated in an 
oven at 65°C for 20 minutes prior to deparaffinization.  For deparaffinizing, slides were 
placed in 3 separate xylene baths for 6 minutes each, followed by  3 minutes in each of 
the following: 100% alcohol, 95 % alcohol, and 80% alcohol. These were followed by a 5 
minute bath in distilled water.  To increase antigenicity, we modified a method of 
microwave antigen retrieval (Shi et al, 1991).  A 0.01M EDTA solution (pH  8.0),  was 
prepared and used for microwave antigen retrieval.  The slides were placed in a 
microwave safe plastic staining rack and container that was filled with the EDTA 
solution.  The container was placed in the microwave (Kenmore # 89626, Sears Roebuck 
and Co, Chicago, IL) and heated for 1 minute 45 seconds on high to bring the solution to 
just under 100° C.  The defrost cycle on the microwave was set for 6 minutes to keep the 
solution at a temperature just under boiling.  After 6 minutes, additional EDTA solution 
was added to fill the container and the defrost cycle was repeated for 6 minutes.  After 
microwaving, the solution was removed from the microwave and the slides remained in 
the hot solution for 20 minutes.  The slides were then rinsed in distilled water and placed 
in a coplin jar with distilled water for 5 minutes.  Unless otherwise specified, the 
remaining steps were performed in a humidity chamber to prevent the slides from drying.  
A 5% solution  of IgG-free BSA (Sigma Chemicals, St. Louis, MO) in PBS was applied 
to the slides as a block for 10 minutes at room temperature.  The slides were rinsed with 
distilled water and  5% pig serum in PBS (Biomeda, Foster City, CA) was applied for 10 
minutes at room temperature.  
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Reaction of lung tissue with primary antibodies: 
 The first primary antibody, sheep anti-human cytokeratin 8 (The Binding Site,  
Birmingham, United Kingdom, England) was diluted 1:10 with Dako Diluent.  The 
second primary antibody,  rabbit anti-rat CYP1A1 (Xenotech, Kansas City, KS) was 
diluted 1:5 with the 1:10 diluted cytokeratin 8 to produce a suspension containing a 1:5 
CYP1A1 and 1:10 cytokeratin 8 antibody solutions.  Using capillary action, the 
suspension containing both primary antibodies was applied to the slides.  The slides were 
incubated overnight at room temperature then placed in an oven at 37°C the following 
morning for 2 hours. The slides were then rinsed thoroughly with distilled water.  Rinsing 
the slides consisted of  a 5 minute bath in a coplin jar with distilled water repeated 3 
times.  
The secondary antibodies, Alexa 594 goat anti-rabbit IgG super highly cross 
absorbed, and Alexa 488 donkey anti-sheep IgG, (Molecular Probes, Eugene, OR) were 
diluted 1: 20 with PBS, vortexed, and centrifuged for 5 minutes.  The supernatant from 
each secondary was applied to each slide for 2 hours at room temperature and kept in a 
dark environment.  The slides were then rinsed very well with distilled water as described 
previously and coverslipped with a glass coverslip and GelMount (Biomeda, Foster City, 
CA).  The slides were stored in the dark and refrigerated until analyzed.  
Visualizing the sites of CYP1A1 and Cytokeratin 8 expression: 
  Using a Quantix Digital Camera (Photometrics, Tucson, AZ) and an Olympus 
AX70 photomicroscope (Olympus, Melville, NY), images were captured as bitmap files.  
CYP1A1 expression was visualized as red fluorescence using  a Texas Red cube with an 
excitation at 460 – 500 nm and bandpass emission of 510 - 560 nm (U-M41004 HQ-TR, 
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Olympus,  Melville, NY). Cytokeratin 8 expression was visualized as green fluorescence 
using a band pass  FITC cube with an excitation at 432.5 - 487.5 nm and bandpass 
emission of 607.5 - 682.5 nm (41001 HQ-FITC, Olympus, Melville, NY).  Five images 
each of both proximal alveolar regions near terminal bronchi, and random, alveolar 
regions between visible terminal bronchi were captured as 1024 x 1024 pixel arrays and 
saved as 12.2 MB bitmap files.  Each image was taken using the green cube, red cube, 
and combined image.    
 
 
21 - Quantification of CYP1A1 and Cytokeratin 8 IF staining in Alveoli 
(Experiment 2)  
Each slide had two regions of interest – the proximal alveolar region (area 
adjacent to the terminal bronchioles, Figure 1A) and the random alveolar region (area 
between visible terminal bronchioles, Figure 1B).  Photos with  vascular endothelium 
from large vessels were avoided for  both regions.  From each slide, 5 images (14,527.68 
micrometers2) were captured from each region using an Olympus AX70 Microscope 
(Melville, NY) with fluorescence capabilitiies, a 60 x objective, and a digital camera 
(Quantix, Photometrix, Tuscon, AZ).   The settings for brighteness, contrast, and gamma 
were held constant for each image.   
Every image was captured and saved on a CD as red, green, and combined red 
and green image.  Each image was then anaylzed by commercial morphometry 
equipment (Metamorph, Universal Imaging, West Chester, PA).   The average from each 
of the 5 images was calculated for each rat.   
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The following measurements were made on each region: 
1) Percent of the region that fluoresced red 
2) Area within the region that fluoresced red 
3) Percent of the region that fluoresced green 
4) Area within the region that fluoresced  green, and 
5) Area of the region that fluoresced both red and green 
Red fluorescence indicated sites of CYP1A1 expression.  Green fluorescence indicated 
sites of cytokeratin 8 expression, which was primarily in airway epithelial cells in the 
airways and alveolar type II cells in alveoli.  
The formulas are defined as follows: 
The percent CYP1A1 and cytokeratin 8 and the area of CYP1A1  and cytokeratin 
8 are values directly measured by Metamorph software.   
Area of CYP1A1 expressed in non-cytokeratin 8 areas (non type II cells) = 
percent of CYP1A1 not in Cytokeratin 8 areas (directly measured by Metamorph 
software)  X  total area of CYP1A1 in image (measured directly  by Metamorph software, 
in square microns). 
Area of CYP1A1 expressed in Cytokeratin 8 areas (alveolar type II cells) = 
percent of CYP1A1 in Cytokeratin 8 areas (directly measured by Metamorph software)  
X  total area of CYP1A1 in image (measured directly  by Metamorph software, in square 
microns). 
Proportional expression of CYP1A1 in alveolar type II cells  =  percent of 
CYP1A1 in Cytokeratin 8 areas (directly measured by Metamorph software)  X  total 
area of CYP1A1 expression  in image (measured directly  by Metamorph software, in 
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square microns)  / Total area of cytokeratin 8 expression in image (measured directly by 
Metamorph, in square microns). 
1A   1B  
Figure   1 Sampling of pulmonary alveoli by digiatl image capture.  
1A .   A representative sample digitally captured and analyzed for Proximal Alveolar 
Regions.  Care was taken not to include open airway or any part of the terminal bronchus.  
1B. The Random Alveolar Regions are areas between and away from visible terminal 
bronchioles.  Care was taken to get areas from separate areas of the slides and between 
airways. 
 
2A 2B 2C  
Figure 2 .  Example of Double-Immunofluorescence Staining.  The bright green staining 
in A represents Cytokeratin 8 positive cells.  The bright red staining represents CYP1A1 
positive cells.  C is a combined (colocalized) image of cytokeratin 8 and CYP1A1 
immunofluorescence.  Yellow staining represents areas that are both CYP1A1 and 
Cytokeratin 8 positive. 
 
22 - Statistical Analysis(Experiments 1, 2 and 3) 
 All analysis was performed using SAS Version 8.2.  Data from the first 
experiment was analyzed as a Three Way Analysis of Variance (ANOVA) comparing IT 
exposure, CYP1A1 inducer, and CYP2B1 inducer.  Pairwise comparisons were done 
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using Fishers Least Significant Difference test (LSD).  The second experiment was 
analyzed as a Two Way Anova comparing IT exposure and inducer effects.  Pairwise 
comparison tests were also done using Fishers LSD.  A One Way Anova was used to 
compare the IT exposures in the third experiment.  Histopathology scores were analyzed 
non-parametrically by the Kruskal-Wallis test.  For all data, values of P<0.05 were 
defined as statistically different. 
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Chapter 4 
Results 
 
1 - Histopathology – Light Microscopy findings in silica-exposed rats 
 During experimental silicosis, rats developed significant accumulations of 
lipoprotein within alveolar spaces two weeks after instillation.   Alveolar type II cells, 
which produce lipoprotein, were also hypertrophied and hyperplastic. These changes 
were accompanied by inflammation.  Alveolar lipoproteinosis, alveolar type II cell 
hyperplasia, and alveolar inflammation were seen in all silica exposed rats but were not 
seen in any saline-instilled control rats.  
The morphologic changes observed in the lungs and lymph nodes in the third 
experiment were converted to quantitative scores and analyzed statistically. The 
following morphological changes in the lung:  alveolitis (p = 0.0123), lipoproteinosis (p = 
0.0008), and type II cell hypertrophy and hyperplasia (p = 0.0069), were significantly 
associated with silica exposure.  Inflammation in the tracheobronchial and parathymic 
lymph nodes was also significantly associated with silica exposure.  A dose response 
relationship was not observed among the silica exposed groups (Table R1). 
Table R1   Pathology Scores from Dose Response Experiment (Experiment 3)1,2 
Group Lipoproteinosis Type II Cell 
Hyperplasia and 
Hypertrophy 
Alveolitis 
NF and Saline 0 (0) 0 (0) 0 (0) 
NF and 5 mg Silica 5 (4 - 6)                      6 (4 - 6) 6 (5 - 7) 
NF and 10 mg Silica 5 (4 - 6) 6 (6 - 6) 6 (5 - 7) 
NF and 20 mg Silica 5 (5 - 5) 6 (6 - 6) 6 (6 - 7) 
 
1.   Pathology score is the sum of the severity (the degree of change) and the 
distribution (the extent of change) scores. 
2. Score is given as median (range) 
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2 - Endotoxin Analysis 
Representative samples of the sterilized silica and the saline solution were 
analyzed for endotoxin and all endotoxin concentrations were found to be under  0.2 
ng/ml. 
 
3 - Experiment 1 -- Exposures to Classical Inducers of CYP Isoforms: The effect of 
inducers of cytochrome P450 on pulmonary CYP2B1 immunohistochemistry in 
silicosis 
      Exposing control and silica-exposed rats to the hepatic CYP2B1 inducer, 
phenobarbital (PB, 100 mg/kg, IP, twice) did not affect the airway and alveolar 
distribution of CYP2B1.  Similarly, exposing control and silica-exposed rats to the 
pulmonary CYP1A1-inducer, ß-naphthoflavone (NF, 50 mg/kg once, IP, once, 3 days 
prior to necropsy), did not alter the airway and alveolar distribution of CYP2B1.  
Exposing control and silica-exposed rats to both PB and NF (50 mg/kg NF once, 100 
mg/kg PB twice) also did not affect the airway and alveolar distribution of CYP2B1.  In 
particular, the hypertrophied alveolar type II cells of silicosis remained devoid of 
immunohistochemically detectable CYP2B1.  The number of morphometrically 
Figure 3  Example of silicotic rat lung.  
Morphologic changes include lipoproteinosis 
(L), type II cell hyperplasia (arrows), and 
inflammation (I) which is manifested as 
alveolitis.  Bar equals 30 microns. 
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measurable CYP2B1 expressing cells was unaffected by silica, NF, PB, or combinations 
of these exposures (Figure 4). 
A B  
Figure 4.  CYP2B1 Immunohistochemistry   A.  Positive non-ciliated airway epithelial 
cells were found in all groups.  B.   Positive cuboidal alveolar epithelial cells ( ) were 
also found in all groups.   Cuboidal alveolar cells without immunoreactivity( ) were 
also found in the silica exposed animals. 
 
3A - The effect of inducers of cytochrome P450 on pulmonary CYP1A1 
immunohistochemistry in silicosis 
 CYP1A1 was consistently detected in the lungs of all rats receiving the CYP1A 
inducer, NF.  No immunohistochemical evidence of CYP1A1 was seen in rats that did 
not receive NF.  NF consistently resulted in the appearance of immunohistochemically 
detectable CYP1A1 in alveoli and airways.  In airways, NF exposure resulted in CYP1A1 
expression in nonciliated airway epithelial cells.  In the vasculature, NF exposure resulted 
in CYP1A1 expression in endothelial cells.  In the alveolus, the thin cytoplasm of 
alveolar type I cells appeared to contain immunoreactive CYP1A1, although reactivity of 
capillary endothelial cells could not be excluded.  Some alveolar lining cells with the 
morphologic appearance of alveolar type II cells contained CYP1A1.  However, the 
hypertrophied alveolar type II cells which are characteristic of silicosis did not express 
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immunohistochemically detectable CYP1A1.  Morphometry indirectly showed that 
silicosis did not significantly affect the number of airway or cuboidal alveolar epithelial 
cells (presumptive alveolar type II cells) expressing CYP1A1 after NF exposure (Figure 
5).  Due to the thin cytoplasm of alveolar type 1 cells and alveolar capillary endothelial 
cells, the number of these cells expressing CYP1A1 could not be counted by 
morphometric analysis of immunohistochemically stained sections.  PB, an inducer of 
hepatic CYP2B1, had no effect on pulmonary CYP1A1 expression. 
 
A B  
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Figure 5.  A. Positive non-ciliated airway epithelial cells 
were only found in groups exposed to  β -naphthoflavone.   
B. Positive plump alveolar epithelial cells( ) were  also 
found only in groups exposed to   β-naphthoflavone.  Plump 
alveolar cells without immunoreactivity( )  were also 
found in silica exposed animals.  C.   CYP1A1 positive cells 
were present after   β-naphthoflavone exposure and the 
number of cells was not significantly increased by 
phenobarbital or silica.   *Significantly different from all 
groups that did not receive NF (p < 0.05). 
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3B - The effect of silicosis on induction of CYP-dependent enzymatic activity 
      Both ECOD (CYP-dependent) and EROD (CYP1A1-dependent) activities were 
significantly increased by NF exposure (p <0.0001).  The  induction of EROD and ECOD 
activity by BNF was significantly inhibited by prior intratracheal administration of silica 
(Figure 6). 
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Figure 6   A and B. The effect of silica exposure on 
EROD and ECOD activity in BNF or PB  exposed rats. 
EROD activity was significantly increased in all animals 
exposed to NF.   There was significantly less EROD 
activity in animals treated with Silica/NF or 
Silica/NF/PB compared with Saline/NF and 
Saline/PB/NF . *Significantly different from all groups 
without NF (p < 0.05). ** Significant decrease from 
Saline/NF and Saline/NF/PB treatment groups (p < 
0.05).  C. ECOD products after 30 minutes of incubation 
showed a significant increase in animals treated with NF 
(p < 0.0001).  Animals also treated with silica had 
significantly less activity than NF exposed control 
animals (p = 0.0033).  
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4A - Experiment 2:  The effect of silicosis on localized expression of CYP1A1 and 
Cytokeratin 8 in the pulmonary alveolus of BNF exposed rats 
Two distinct areas of the lung were analyzed, the proximal alveolar region (PAR) 
and the random alveolar region (RAR).  The proximal alveolar region is the area 
immediately adjacent to the terminal bronchi and the random areas are sampled as 
alveolar regions between visible terminal bronchi.   In both the RAR and PAR alveolar 
regions, CYP1A1 was not observed in the lungs of control rats and intense red 
fluorescence consistent with induction of CYP1A1 was seen in all rats receiving i.p. NF. 
Both control and silica-treated rats had plump, cuboidal cells that were morphologically 
consistent with alveolar type II cells and fluoresced green, indicating cytokeratin 8 
expression.   
The Proximal Alveolar Region: 
Cytokeratin 8 was expressed in all groups.   However, expression was significantly 
increased in groups exposed to silica.  CYP1A1 was only detected in animals exposed to 
NF (Figures 7 and 8).  The amount of CYP1A1 expressed in type II cells was not found 
to be significantly different between saline and silica groups treated with NF.  The 
proportional expression of CYP1A1 in type II cells (the amount of CYP1A1 expressed in 
type II cells corrected for increases in type II cell number) was found to be significantly 
reduced in rats exposed to both NF and silica compared to NF-exposed rats without 
silicosis (Figures 7 and 8).  
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  A.    Silica/Corn oil    B. Silica/NF 
             
  C.    Saline/Corn Oil    D. Saline/NF 
         
Figure 7  Immunofluorescenct localization of CYP1A1 and Cytokertin 8 in Proximal 
Alvelor Regions.  Animals that did not receive NF, did not express any detectible 
CYP1A1.  A. In  silica/corn oil exposed animal, many plump, cuboidal, cytokeratin 8 
positive(green), alveolar type II cells are found.  B.  In silica/NF exposed animals, notice 
the plump, cuboidal, cytokeratin 8 positive cells(green) are abundant, while long, thin, 
alveolar cells are CYP1A1(red) positive.  Yellow staining represents cells expressing 
both cytokeratin 8 and CYP1A1.  C.  A saline/corn oil exposed animal has far less 
cytokeratin 8 positive (green) cells, and these cells are not as hypertrophied.  In addition, 
CYP1A1 expression is not observed.  D. In a saline/NF exposed animal, there are again 
far fewer and smaller cytokeratin 8 positive cells, and CYP1A1 expression is localized  in 
the thin, long alveolar cells.  Notice that there are more CYP1A1 positive cells in the 
septum of saline and NF exposed animal than the silica and NF exposed animal. 
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Random alveolar region:  
CYP1A1 expression was consistently observed in NF exposed animals. 
Cytokeratin 8 was expressed in all groups but there was not a significant difference in 
expression between groups. As in the proximal alveolar region groups, there was not a 
significant difference in the area of CYP1A1 expressed in either type II cells or non type 
II cells.  The proportional expression of CYP1A1 in type II cells was decreased in 
silica/bnf treated groups compared with saline/nf groups, but this difference was not 
statistically significant (Figures 9 and 10). 
Figure 8 Proximal Alveolar Regions – A. The 
area of alveolus containing cytokeratin 8 
expressing cells was significantly increase by 
silica exposure (p =0.0003). * significantly 
different from saline groups.  B.  The 
proportional CYP1A1 expression in type II cells 
was found to have significantly less expression in 
silica/NF treated animals compared to saline/NF 
treated animals (p=0.0082).  * Significantly 
different compared to groups without NF and the 
silica/NF group.  C.  As expected, only animals 
receiving NF were positive for CYP1A1 (p < 
0.0001).  * Significantly different compared to 
groups not receiving NF. 
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A. Silica/Corn Oil   B. Silica/NF 
            
C. Saline/Corn Oil   D. Saline/NF 
Figure 9  Immunofluorescent localization of CYP1A1 and cytokeratin 8 in Random 
Alveolar Regions.  Animals exposed only to saline (A) had comparable expression of 
cytokeratin 8 in the random alveolar regions as compared with silica exposed animals 
(C).   Animals that did not receive NF did not express CYP1A1.  Animals exposed to NF 
and either saline (B) or silica (D) expressed CYP1A1, but expression was not 
significantly different in the random alveolar regions. 
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4B - The effect of silicosis on induction of CYP1A1 and CYP2B1-dependent 
enzymatic activity 
 CYP1A1 dependent EROD activity was significantly increased in groups that 
received NF.  There was also a significant decrease in EROD activity of silica/NF groups 
compared to saline/NF groups. PROD (CYP2B1 dependent) activity was also found to be 
significantly lower in groups exposed to silica when compare to saline groups.  NF 
treatment did not have a significant effect on PROD activity (Figure 11). 
Figure 10  Random Alveolar Regions – A.  The 
proportional CYP1A1 expression in type II 
cells is lower in silica/nf treated animals when 
compared to silica/corn oil animals. However it 
is not significantly lower (p = 0.4388).  
 * Significantly different from groups without 
NF. B. Cytokeratin 8 expression is not 
significantly different among any of the groups 
in the random alveolar regions (p = 0.6075).   
C.  CYP1A1 expression is primarily expressed 
in NF exposed rats and is not significantly 
different between the silica and saline groups  
(p = 0.3934).  ).  * Significantly different from 
groups without NF. 
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Figure 11  A.  EROD (CYP1A1 dependent) activity is significantly increased in groups 
that received NF(*) (p < 0.0001), and there is a significant decrease in activity in 
CYP1A1 induction by NF in silicotic rats (**) (p = 0.0153) groups compared to saline/nf 
groups.  B. Groups receiving silica had significantly less PROD (CYP2B1) activity than 
groups than saline groups (p < 0.0001).  NF did not have a significant effect on PROD 
activity.  
 
4C - The effect of  silicosis on CYP1A1 protein 
Western blot analysis was performed for CYP1A1.  As with immunofluorescence, 
groups that did not receive NF, did not express detectable CYP1A1 protein.  For groups 
receiving NF, the % of positive control was significantly less in silica groups compared 
to saline groups (Figure 12). 
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Figure 12   Western Blot analysis of CYP1A1.  
CYP1A1 was only detected in groups that received 
BNF.  When expressed as percent of positive 
control, there was significantly less protein 
expressing in silica/nf groups than saline/nf groups 
(*) (p = 0.0009).   
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5 - Experiment 3:Silica Dose Response Study with Exposure to Classical Inducer of 
CYP1A1:  The effect of silicosis on induction of CYP1A1 and CYP2B1-dependent 
enzymatic activity 
BNF induced CYP1A1 dependent activity (EROD) was significantly lower in all 
silica exposed groups compared to the saline group.  There were no significant 
differences between silica exposed groups.  CYP2B1- dependent PROD activity also 
showed significant decreases in activity of all silica groups compared to saline.  There 
also was not a significant difference between the silica groups (Figure 13). 
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Figure 13  For both PROD (CYP2B1 dependent) and EROD (CYP1A1 dependent) 
activity was significantly lower in all BNF and silica exposed groups (*) compared to the 
BNF and saline exposed group.  (A. p<0.0001, B. p = 0.0035). 
 
 
5A - The effect of  silicosis on CYP1A1 and CYP2B1 proteins 
By western blot analysis, silica and BNF exposed groups have significantly less 
CYP1A1 protein than the BNF and  saline exposed group.    
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Western Blot analysis of CYP2B1 found all BNF and silica groups  have significantly 
less CYP2B1 protein than the BNF and  saline exposed group, but there were no 
significant differences amongst the silica treated groups(Figures 14 and 15). 
 
A   B  
      MW  B  1   2    3    4    5   6     7    8    9  10 B  +C        +C  B    1     2     3    4   5     6      7    8   9     10  MW +C 
    Immunoblot for CYP1A1        Immunoblot for CYP2B1 
  
Figure 14    Lanes marked MW stand for Molecular Weight marker, B stands for blank, 
and +C stands for positive control (BNF treated rat liver microsomes for CYP1A1 and 
Phenobarbital treated liver microsomes for CYP2B1)  For this experiment, all animals 
received NF.  A is an Immunoblot for CYP1A1 – Lanes 1 and 2 were rat lung 
microsomes treated with 20mg silica,  Lanes 3 and 4 received 10 mg silica, lanes 5, 6, 
and 7 received, 5mg silica, and lanes 8, 9, and 10 received saline.  B is an immunoblot for 
CYP2B1 – Lanes 1, 2, 3 received saline, lanes 4 and 5 received 5 mg silica, lanes 6, 7, 
and 8 received 10 mg silica, and lanes 9 and 10 received 20 mg silica.   In both blots, 
silica treated animals expressed less protein (CYP1A1 and CYP2B1) than saline treated 
rats.  
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Figure 15   A.  Graph quantifying western blots of CYP1A1 protein expression. BNF and 
silica exposed rats (*) expressed significantly less CYP1A1 protein than rats exposed to 
BNF and the IT vehicle (saline) (p = 0.0039).  B. All BNF and silica exposed rat groups 
expressed less CYP2B1 protein than rats exposed to BNF and the IT vehicle (saline); 
however only doses of 5 mg and 10 mg  (*) were significantly different. 
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Chapter 5 
Discussion 
 
It is important to note that these experiments were carried out on animals exposed 
to β-naphthoflavone, a CYP1A1 inducer.  EROD and ECOD activity in rats only exposed 
to saline or silica in the first experiment were found to be comparable with results from 
Miles et al, 1993 and 1994.  EROD activity was increased in animals exposed to silica 
compared to saline.  Levy et al, 1997 performed immunohistochemistry for CYP1A1 and 
CYP2B1 in the lungs of rats that were only exposed to silica or saline.  Again, looking at 
only saline or silica exposed animals from our first experiment, our results were 
comparable.  CYP1A1 was not detected in any animals not receiving NF and although 
CYP2B1 was detected, there was not a significant difference in the number of cells 
expressing CYP2B1 between the silica and saline exposed animals.  Differences in 
CYP1A1 activity were only found when animals were exposed to CYP1A1 inducers with 
and without silica exposure.  In NF-exposed rats, silica caused a decrease in CYP1A1 
activity, CYP1A1 protein expression, and proportional expression in epithelial type II 
cells in animals exposed to silica and inducer. 
In this study a technique a technique was developed for immunofluoresent 
labeling and quantifying of alveolar type II cells that was time efficient and allowed for 
ease of data quantification.  Previous research on alveolar type II cell proliferation has 
been performed using electron microscopy techniques that were time consuming and 
costly and required special fixation (Miller and Hook, 1990).  In 1987, Miller et al 
described a technique using alkaline phosphatase immunohistochemistry that was a vast 
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improvement over electron microscopy.  However, with this technique, fixation and the 
immunhistochemistry procedure must be carried out at 4 ۫ C to preserve enzyme activity 
(Miller, et al 1987).  In the alveolar regions, only epithelial type II cells stained positively 
for alkaline phosphatase making them easy to recognize under a microscope.  However, 
photomicrographs had to be taken and someone counted the number of positive cells.  
Although this was more cost efficient and less time consuming than electron microscopy, 
our method had advantages which included simplified tissue preservation, technical 
simplicity and rapid quantitative analysis.  Using our method, the lungs could be fixed at 
room temperature with 10% neutral buffered formalin overnight and embedded in 
paraffin.  They could be stored in paraffin for at least a year prior to analysis.  
Immunofluorescent staining was simple relative to alkaline phosphatase 
immunohistochemistry.  Staining for cytokeratin 8 did not prevent subsequent staining 
with different fluoroprobes which permitted staining of 2 or more different antigens in a 
single tissue section.  Using a fluorescent microscope with an attached digital capture 
allowed for instantaneous capture of the image.  The instantaneous capture prevented the 
fluorescent fading which has long been a negative consideration with 
immunofluorescence  (Johnson et al, 1982).  The immunofluorescent images could then 
be saved onto a disk and the image could be analyzed by a morphometry program.  
Morphometry programs quickly quantified the amount of a fluoroprobe present in an 
image.   Numerical area values for area of fluorochrome staining, and percent of the total 
area staining with a fluorochrome, and colocalization of multiple fluorochromes were 
easily determined and loaded into analytical programs.  Using IF with quantitative 
morphometry, slides were rapidly analyzed for alveolar type II cell proliferation.  In 
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addition, we localized the expression of CYP1A1 in relation to the sites of cytokeratin 8 
expression.   
We demonstrated that the proximal alveolar region was the site of specific cell 
changes.  We were able to show proliferation of alveolar type II cells in this region in 
response to silica exposure.  We also were able to show that proportional CYP1A1 
expression decreased in animals exposed to both silica and the NF inducer when 
compared to animals exposed to just NF.  This was an important region to analyze as it 
was the site of particle deposition in intratracheally instilled rats (Brain et al, 1976).  
Inhalation methods of exposure resulted in deeper deposition of particles and may have 
produced different results.  However, we were able to use our technique for detecting 
alveolar epithelial cell hypertrophy and hyperplasia and localizing CYP1A1 cellular 
expression and identified the site of particle deposition as the site where expression 
changed. 
 Smoking status is a critical factor in lung cancer development and should be a 
controlled variable in epidemiological studies of lung cancer involving other potential 
pulmonary carcinogens.  However, one epidemiologic study suggested that people 
exposed to both silica and cigarette smoke had no difference in risk or even a reduced 
risk for lung cancer compared to  people exposed to silica alone (Cocco, et al 1991).   
Many epidemiological studies either did not control, or inadequately controlled for 
cigarette smoke exposure.   Pairon et al, 1991, reported that in some studies, smoking 
was not used as a variable at all. Although IARC added silica to its list of human 
carcinogens in 1997, some studies have not yet listed silica as a carcinogen (Tsuda et al, 
2002) and some studies have disputed the carcinogen designation by IARC (Graham et 
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al, 2004).    Our studies showed that the model, PAH, NF was not a co-variable, but a 
modifier of lung cancer risk.  Thus, it may be appropriate to analyze data from potential 
lung carcinogens both with control for cigarette smoking and with separate analyses for 
potential carcinogenesis in smokers and non-smokers. 
In vivo and in vitro experiments have shown that inflammation decreases 
CYP1A1 activity (Tian et al, 1999; Ke et al, 2001; Paton and Renton, 1998)   and 
inflammation was produced by silica exposure (Porter et al,  2001; Driscoll et al, 1991; 
Castranova et al, 2002).  Several cytokines involved in lung inflammation, such as TNF-
α and NFκB interfered with CYP1A1 induction (Tian et al, 1999; Ke et al, 2001; Paton 
and Renton, 1998).    Experiments by Porter et al (2001), showed increases in both TNFα  
and NFКB in alveolar lavage fluid in rats exposed to silica.  NFКB was shown by Tian et 
al (1999) to interact with the Ah receptor.  This interaction was a possible reason for the 
CYP1A1 inhibition by cytokines.  The binding to the XRE by the AhR and ARNT 
produced  increased  histone acetylation, an important activator of gene transcription (Ke 
et al, 2001).  TNF-α treatment inhibited this acetylation and inactivated the CYP1A1 
promoter, thereby inhibiting CYP1A1 induction (Ke et al, 2001). Cytokines like TNF-α 
are released in response to inflammatory injuries such as those caused by exposure to 
silica could possibly explain the decrease in CYP1A1 activity and expression in rats 
exposed to inducers of CYP1A1 and silica.  Our studies showed that down regulation of 
CYP1A1 expression and activity occurred in vivo, in the rat lung after exposure to silica, 
a known inducer of inflammation. We confirmed inflammation by histopathology in our 
study 
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Future studies might include extending the time period after intratracheal 
exposure.  The animals in these studies were sacrificed 14 days after receiving a bolus 
intratracheal instillation of silica.  It would be interesting to see if the significant changes 
found in the proximal alveolar region would still be present at 4 weeks or more following 
instillation.  Another consideration to explore would be to administer the silica via 
inhalation exposure.  Inhalation is considered a more natural method of exposure but 
costs and time would increase.   Since inflammation was observed in our study and has 
also been demonstrated following inhalation exposures (Driscoll et al, 1991, Castranova 
et al, 2002, Porter et al, 2001,  Castranova et al, 1996 )  the  acute effects of silica on 
down regulation of CYP1A1 expression are likely to be unaffected by the method of 
exposure. 
Exposure to 5 milligrams of silica was sufficient to inhibit CYP1A1 or CYP2B1 
expression and activity.  Histopathological changes associated with silica exposure 
(alveolitis, alveolar type II cell hyperplasia and hypertrophy, and lipoproteinosis) were 
also fully manifested in the lungs of rats at exposures of 5 mg silica. Perhaps exposing 
the animals to even smaller amounts of silica or allowing for larger increases between 
doses (i.e., 5, 25, and 50 mg treatments) would show a dose response effect.  In our study, 
histopathologic manifestations of inflammation were also unaffected by the dose at this 
time point.  Thus, doses or time points that changed inflammation would be more 
revealing in evaluating the relationship between silica-induced inflammation and down-
regulation of CYP1A1 activity and expression. 
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Conclusions 
 
• Xenobiotic metabolism is altered by silica exposure and is localized to a common 
site for deposition of silica and other respirable particles, the proximal alveolar 
duct region. 
• These finding suggest that silica exposure modifies carcinogenic effects of PAHs, 
such as these in cigarette smoke. 
• The proximal alveolar region is very important for inhaled carcinogens. 
• Silica exposures of 5, 10, or 20 mgs each significantly decreased CYP1A1 and 
CYP2B1 activity in NF-exposed rats, but a dose response relationship was not 
detected. 
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